Patent details

EN | LT

LT - NOVEL POLYMORPHIC CRYSTAL FORMS OF 5-(2-{[6-(2,2-DIFLUORO-2-PHENYLETHOXY)HEXYL]AMINO}-1-(R)-HYDROXYETHYL)-8-HYDROXYQUINOLIN-2(1H)-ONE, HEMINAPADISYLATE AS AGONIST OF THE 2 ADRENERGIC RECEPTOR.

EN - NOVEL POLYMORPHIC CRYSTAL FORMS OF 5-(2-{[6-(2,2-DIFLUORO-2-PHENYLETHOXY)HEXYL]AMINO}-1-(R)-HYDROXYETHYL)-8-HYDROXYQUINOLIN-2(1H)-ONE, HEMINAPADISYLATE AS AGONIST OF THE 2 ADRENERGIC RECEPTOR.

Legal status

Patent not validated

Bibliographic data

Indications of the International Patent Classification (IPC)
(51)	INT.CL.	C07D 215/26
		A61K 31/4704
		A61P 11/00

European patent
(11)	Number of the document	2828242
(13)	Kind of document	T
(96)	European patent application number	13719407.2
	Date of filing the European patent application	2013-03-15
(97)	Date of publication of the European application	2015-01-28
(45)	Date of publication and mention of the grant of the patent	2017-10-04
(46)	Date of publication of the claims translation

PCT application
(86)	Number	PCT/EP2013/055488
	Date	2013-03-15

PCT application publication
(87)	Number	WO 2013/139712
	Date	2013-09-26

Priority applications
(30)	Number	Date	Country code
	12382101	2012-03-20	EP
	201261622266 P	2012-04-10	US

Inventors
(72)	AMAT MESTRES, Gemma, ES BALAGUER ARDANUY, Elvira, ES CARRERA CARRERA, Francesc, ES MARCHUETA HEREU, Iolanda, ES MOYES VALLS, Enrique, ES

Grantee
(73)	Almirall S.A., Ronda del General Mitre, 151, 08022 Barcelona, ES

Title
(54)	NOVEL POLYMORPHIC CRYSTAL FORMS OF 5-(2-{[6-(2,2-DIFLUORO-2-PHENYLETHOXY)HEXYL]AMINO}-1-(R)-HYDROXYETHYL)-8-HYDROXYQUINOLIN-2(1H)-ONE, HEMINAPADISYLATE AS AGONIST OF THE 2 ADRENERGIC RECEPTOR.
	NOVEL POLYMORPHIC CRYSTAL FORMS OF 5-(2-{[6-(2,2-DIFLUORO-2-PHENYLETHOXY)HEXYL]AMINO}-1-(R)-HYDROXYETHYL)-8-HYDROXYQUINOLIN-2(1H)-ONE, HEMINAPADISYLATE AS AGONIST OF THE 2 ADRENERGIC RECEPTOR.